Kesimpta® (Ofatumumab) in Swiss Multiple Sclerosis Patients - an Observational Study

Clinical trial NCT05285904 · COMPLETED

Trial details

NCT number: NCT05285904
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Sclerosis

Start date: 2022-05-12
Primary completion: 2026-02-04
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.